Cardiology
M-A: Hypothermic vs. normothermic temperature control after cardiac arrest.
24 Jun, 2022 | 11:51h | UTCHypothermic versus Normothermic Temperature Control after Cardiac Arrest – NEJM Evidence
Related:
ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (if the link is paywalled, try this one)
An update on refractory hypertension.
24 Jun, 2022 | 11:44h | UTCAn Update on Refractory Hypertension – Current Hypertension Reports
AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents.
23 Jun, 2022 | 13:03h | UTCNews Release: Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk – American Heart Association
RCT: Effectiveness and safety of early initiation of poststernotomy cardiac rehabilitation exercise training.
23 Jun, 2022 | 12:59h | UTCEffectiveness and Safety of Early Initiation of Poststernotomy Cardiac Rehabilitation Exercise Training: The SCAR Randomized Clinical Trial – JAMA Cardiology (free for a limited period)
Commentary on Twitter
RCT found starting exercise 2 weeks post-sternotomy was as effective as starting at 6 weeks. Clinicians and cardiac rehabilitation professionals can recommend starting exercise training as early as 2 weeks post-sternotomy. https://t.co/MpBhRmyfUh
— JAMA Cardiology (@JAMACardio) June 22, 2022
RCT: Effect of MRI-guided fibrosis ablation vs. conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation.
23 Jun, 2022 | 12:57h | UTCEffect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial – JAMA (free for a limited period)
News Release: Global AFib study finds simple approach is best for ablation procedures – Tulane University
Commentary on Twitter
Randomized clinical trial of patients with persistent #atrialfibrillation found no significant difference in atrial arrhythmia recurrence in the MRI-guided fibrosis ablation group compared with the pulmonary vein isolation only group. https://t.co/mCyNR4rpTH
— JAMA (@JAMA_current) June 21, 2022
M-A: Early versus delayed complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel disease.
23 Jun, 2022 | 10:11h | UTC
USPSTF Statement: The current evidence is insufficient to recommend vitamins for the prevention of cardiovascular disease or cancer.
22 Jun, 2022 | 12:21h | UTCEvidence Report and Systematic Review: Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer – JAMA
Patient Page: Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer – JAMA
Editorial: Why Too Many Vitamins Feels Just About Right – JAMA Internal Medicine
Author Interview: Why Too Many Vitamins Feels Just About Right – JAMA
Commentary: Vitamins, Supplements Useless for Most People: Expert Panel – HealthDay
Cohort Study: Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA.
22 Jun, 2022 | 12:07h | UTCCommentaries:
COVID-19 mRNA vaccination and myocarditis or pericarditis – The Lancet
Myocarditis and Pericarditis After the COVID-19 mRNA Vaccination – American College of Cardiology
Related:
Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Guidelines for the use of cardiac magnetic resonance in pediatric congenital and acquired heart disease.
22 Jun, 2022 | 11:31h | UTC
Cohort Study: Association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease.
22 Jun, 2022 | 11:18h | UTC
Cardiovascular disease in primary Sjögren’s syndrome: raising clinicians’ awareness.
22 Jun, 2022 | 10:55h | UTC
Cohort Study: Cardiometabolic multimorbidity, genetic risk, and dementia.
21 Jun, 2022 | 11:01h | UTCNews Release: Multiple heart-related conditions linked to triple dementia risk regardless of genetics – University of Oxford
Related:
Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text) AND Commentary: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology
Preventing dementia: what’s the evidence? – Evidently Cochrane
Cohort Study: Cardiometabolic multimorbidity linked to accelerated cognitive decline and dementia progression.
21 Jun, 2022 | 10:59h | UTCNews Release: Diabetes and cardiovascular disease increase dementia risk – Karolinska Institutet
Related:
Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text) AND Commentary: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology
Preventing dementia: what’s the evidence? – Evidently Cochrane
Cohort Study: Association of cardiovascular risk trajectory with cognitive decline and incident dementia.
21 Jun, 2022 | 10:58h | UTCCommentary: Heart Risk Factors Can Be Recipe for Dementia – HealthDay
Related:
Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text) AND Commentary: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology
Preventing dementia: what’s the evidence? – Evidently Cochrane
Commentary on Twitter
Study findings show that the longitudinal, cumulative trajectory of #cardiovascular risk is predictive of #dementia risk and associated with the emergence of memory decline. Read the article: https://t.co/CT1NQ63sXO #NeuroTwitter pic.twitter.com/KMGAPLQFe7
— Neurology Journal (@GreenJournal) May 17, 2022
M-A: Comparison of bifurcation techniques for percutaneous coronary intervention.
21 Jun, 2022 | 10:50h | UTC
Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study.
21 Jun, 2022 | 10:44h | UTC
Commentary on Twitter
#Bariatric surgery improves metabolic health of patients, but what are the risks if they have had MI before surgery?
National dataset matched 16000 pts🇸🇪
Heart dis assoc w/🔼 cardiac events post op, plus 🔼risk of SBO and stricture.#SoMe4Surgery https://t.co/iHsZiHIgdG pic.twitter.com/v2SXMpcZd3— BJS Open (@BjsOpen) June 17, 2022
Cohort Study: Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes.
20 Jun, 2022 | 10:36h | UTC
Commentary on Twitter
Still remember working on this in 2019 but it's out today!
Gamma-GT level has a strong association with mortality outcomes and could add to the prediction of CV mortality
https://t.co/0lzqGfgiGc pic.twitter.com/C8tSZLWlI2— Fred Ho (@fredho42) May 13, 2022
Under a CC BY-NC-ND 4.0 license
Review, Statements, and Recommendations: Cuffless blood pressure measuring devices.
20 Jun, 2022 | 01:26h | UTCRelated:
Perspective | Cardiovascular meta-analyses: fool’s gold or gold for fools?
20 Jun, 2022 | 01:15h | UTCCardiovascular meta-analyses: fool’s gold or gold for fools? – European Heart Journal
Prospective head-to-head comparative study: Functional stress imaging to predict abnormal coronary fractional flow reserve.
20 Jun, 2022 | 01:10h | UTC
Commentary on Twitter
Functional stress imaging to predict abnormal coronary fractional flow reserve: new insights from the PACIFIC 2 study!https://t.co/5N0dOW2Rem#PET #MRI #FFR #CCS #coronary #cardiotwitter @escardio @ESC_Journals pic.twitter.com/WCoA0cOgd9
— EHJ Editor-in-Chief (@ehj_ed) June 17, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A: Heat exposure and cardiovascular health outcomes.
20 Jun, 2022 | 01:00h | UTC
Commentary on Twitter (thread – click for more)
New review out in @TheLancetPlanet on #heat from #climatechange and #cardiovascular #publichealth. Shows 1deg Celsius increases cardio mortality by 2.1%. https://t.co/RLsGU8dIS7
— Nicole Iroz Elardo (@NIrozElardo) June 14, 2022
Cardiac xenotransplantation: challenges, evolution, and advances.
20 Jun, 2022 | 00:58h | UTCCommentary: Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off – TCTMD
Related:
In 1st, US surgeons transplant pig heart into human patient – Associated Press
Results of Two Cases of Pig-to-Human Kidney Xenotransplantation – New England Journal of Medicine (link to abstract – $ for full-text)
After a flurry of firsts, xenotransplantation is suddenly back in the spotlight – STAT
AHA Scientific Statement: Revascularization for renovascular disease.
17 Jun, 2022 | 11:50h | UTCTop Things to Know: Revascularization for Renovascular Disease – American Heart Association
Commentary: When is Renovascular Hypertension Amenable to Revascularization – American Heart Association
Post Hoc Secondary Analysis of RCT: Rivaroxaban monotherapy is associated with better outcomes vs. combination therapy with antiplatelets in patients with atrial fibrillation and stable coronary artery disease.
17 Jun, 2022 | 11:07h | UTCRivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial – JAMA Cardiology (free for a limited period)
Commentaries:
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More? – JAMA Cardiology (free for a limited period)
Rivaroxaban Monotherapy Linked to Lower Event Risk in Patients with AF, Stable CAD – HCPLive
Commentary on Twitter
In this post-hoc study of the AFIRE RCT, recurrent event analyses showed that rivaroxaban monotherapy was associated with lower risks of total thrombotic and/or bleeding events than rivaroxaban plus antiplatelet therapy in patients with AF and stable CAD. https://t.co/TGwatvlrKR
— JAMA Cardiology (@JAMACardio) June 15, 2022
Cohort Study: Association of sitting time with mortality and cardiovascular events in high-income, middle-income, and low-income countries.
17 Jun, 2022 | 11:05h | UTCAssociation of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries – JAMA Cardiology (free for a limited period)
Commentary: Trade the chair for fresh air: Sitting time and cardio health – Simon Fraser University
Commentary from one of the authors on Twitter
Our study in 105K people from #PURE study:
🌟⬆️ sitting associated with >early death & heart disease
🌟association > in low income countries
🌟being active can counteract risk
🌟every 30 min of sitting replaced by #exercise, risk⬇️ 2%#healthy@JAMACardio: https://t.co/rR61SolkXs pic.twitter.com/ESUFXy6Pvj— Scott Lear, PhD (@DrScottLear) June 15, 2022